Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

The Biophysical Interaction of the Danger-Associated Molecular Pattern (DAMP) Calreticulin with the Pattern-Associated Molecular Pattern (PAMP) Lipopolysaccharide.

Pandya UM, Egbuta C, Abdullah Norman TM, Chiang CE, Wiersma VR, Panchal RG, Bremer E, Eggleton P, Gold LI.

Int J Mol Sci. 2019 Jan 18;20(2). pii: E408. doi: 10.3390/ijms20020408.

2.

Hormonal and Growth Regulation of Epithelial and Stromal Cells From the Normal and Malignant Endometrium by Pigment Epithelium-Derived Factor.

Daubriac J, Pandya UM, Huang KT, Pavlides SC, Gama P, Blank SV, Shukla P, Crawford SE, Gold LI.

Endocrinology. 2017 Sep 1;158(9):2754-2773. doi: 10.1210/en.2017-00028.

PMID:
28911166
3.

Heightened autoantibody immune response to citrullinated calreticulin in bronchiectasis: Implications for rheumatoid arthritis.

Clarke A, Perry E, Kelly C, De Soyza A, Heesom K, Gold LI, Ollier W, Hutchinson D, Eggleton P.

Int J Biochem Cell Biol. 2017 Aug;89:199-206. doi: 10.1016/j.biocel.2017.06.013. Epub 2017 Jun 24.

PMID:
28652209
4.

TGF-β activates APC through Cdh1 binding for Cks1 and Skp2 proteasomal destruction stabilizing p27kip1 for normal endometrial growth.

Pavlides SC, Lecanda J, Daubriac J, Pandya UM, Gama P, Blank S, Mittal K, Shukla P, Gold LI.

Cell Cycle. 2016;15(7):931-47. doi: 10.1080/15384101.2016.1150393.

5.

High-level secretion of native recombinant human calreticulin in yeast.

Čiplys E, Žitkus E, Gold LI, Daubriac J, Pavlides SC, Højrup P, Houen G, Wang WA, Michalak M, Slibinskas R.

Microb Cell Fact. 2015 Oct 15;14:165. doi: 10.1186/s12934-015-0356-8.

6.

Inhibitors of SCF-Skp2/Cks1 E3 ligase block estrogen-induced growth stimulation and degradation of nuclear p27kip1: therapeutic potential for endometrial cancer.

Pavlides SC, Huang KT, Reid DA, Wu L, Blank SV, Mittal K, Guo L, Rothenberg E, Rueda B, Cardozo T, Gold LI.

Endocrinology. 2013 Nov;154(11):4030-45. doi: 10.1210/en.2013-1757. Epub 2013 Sep 13.

7.

Estrogen and progesterone regulate p27kip1 levels via the ubiquitin-proteasome system: pathogenic and therapeutic implications for endometrial cancer.

Huang KT, Pavlides SC, Lecanda J, Blank SV, Mittal KR, Gold LI.

PLoS One. 2012;7(9):e46072. doi: 10.1371/journal.pone.0046072. Epub 2012 Sep 27.

8.

Exogenous calreticulin improves diabetic wound healing.

Greives MR, Samra F, Pavlides SC, Blechman KM, Naylor SM, Woodrell CD, Cadacio C, Levine JP, Bancroft TA, Michalak M, Warren SM, Gold LI.

Wound Repair Regen. 2012 Sep-Oct;20(5):715-30. doi: 10.1111/j.1524-475X.2012.00822.x. Erratum in: Wound Repair Regen. 2013 Mar-Apr;21(2):337.

PMID:
22985041
9.

Calreticulin: non-endoplasmic reticulum functions in physiology and disease.

Gold LI, Eggleton P, Sweetwyne MT, Van Duyn LB, Greives MR, Naylor SM, Michalak M, Murphy-Ullrich JE.

FASEB J. 2010 Mar;24(3):665-83. doi: 10.1096/fj.09-145482. Epub 2009 Nov 25. Review.

10.

TGFbeta prevents proteasomal degradation of the cyclin-dependent kinase inhibitor p27kip1 for cell cycle arrest.

Lecanda J, Ganapathy V, D'Aquino-Ardalan C, Evans B, Cadacio C, Ayala A, Gold LI.

Cell Cycle. 2009 Mar 1;8(5):742-56. Epub 2009 Mar 16.

PMID:
19221482
11.

Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum.

Michalak M, Groenendyk J, Szabo E, Gold LI, Opas M.

Biochem J. 2009 Feb 1;417(3):651-66. doi: 10.1042/BJ20081847. Review.

PMID:
19133842
12.

Calreticulin enhances porcine wound repair by diverse biological effects.

Nanney LB, Woodrell CD, Greives MR, Cardwell NL, Pollins AC, Bancroft TA, Chesser A, Michalak M, Rahman M, Siebert JW, Gold LI.

Am J Pathol. 2008 Sep;173(3):610-30. doi: 10.2353/ajpath.2008.071027.

13.

Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats.

Laping NJ, Everitt JI, Frazier KS, Burgert M, Portis MJ, Cadacio C, Gold LI, Walker CL.

Clin Cancer Res. 2007 May 15;13(10):3087-99.

14.

Transforming growth factor-beta, estrogen, and progesterone converge on the regulation of p27Kip1 in the normal and malignant endometrium.

Lecanda J, Parekh TV, Gama P, Lin K, Liarski V, Uretsky S, Mittal K, Gold LI.

Cancer Res. 2007 Feb 1;67(3):1007-18.

15.

Overview of the role for calreticulin in the enhancement of wound healing through multiple biological effects.

Gold LI, Rahman M, Blechman KM, Greives MR, Churgin S, Michaels J, Callaghan MJ, Cardwell NL, Pollins AC, Michalak M, Siebert JW, Levine JP, Gurtner GC, Nanney LB, Galiano RD, Cadacio CL.

J Investig Dermatol Symp Proc. 2006 Sep;11(1):57-65. Review.

16.

The activation function-1 domain of estrogen receptor alpha in uterine stromal cells is required for mouse but not human uterine epithelial response to estrogen.

Kurita T, Medina R, Schabel AB, Young P, Gama P, Parekh TV, Brody J, Cunha GR, Osteen KG, Bruner-Tran KL, Gold LI.

Differentiation. 2005 Jul;73(6):313-22.

PMID:
16138832
17.

Postirradiation morphea and subcutaneous polyarteritis nodosa: case report and literature review.

Reddy SM, Pui JC, Gold LI, Mitnick HJ.

Semin Arthritis Rheum. 2005 Apr;34(5):728-34. Review.

PMID:
15846588
18.

Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review.

Arslan AA, Gold LI, Mittal K, Suen TC, Belitskaya-Levy I, Tang MS, Toniolo P.

Hum Reprod. 2005 Apr;20(4):852-63. Epub 2005 Feb 10. Review.

PMID:
15705628
20.
21.

Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.

Parekh TV, Gama P, Wen X, Demopoulos R, Munger JS, Carcangiu ML, Reiss M, Gold LI.

Cancer Res. 2002 May 15;62(10):2778-90.

23.
24.

Quantitative assessment of cranial defect healing and correlation with the expression of TGF-beta.

Gosain AK, Song L, Yu P, Mehrara BJ, Maeda CY, Gold LI, Longaker MT.

J Craniofac Surg. 2001 Jul;12(4):401-4.

PMID:
11482629
26.

Osteogenesis in cranial defects: reassessment of the concept of critical size and the expression of TGF-beta isoforms.

Gosain AK, Song L, Yu P, Mehrara BJ, Maeda CY, Gold LI, Longaker MT.

Plast Reconstr Surg. 2000 Aug;106(2):360-71; discussion 372.

PMID:
10946935
27.
28.

The role for transforming growth factor-beta (TGF-beta) in human cancer.

Gold LI.

Crit Rev Oncog. 1999;10(4):303-60. Review.

PMID:
10654929
29.
30.

Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis.

di Mola FF, Friess H, Martignoni ME, Di Sebastiano P, Zimmermann A, Innocenti P, Graber H, Gold LI, Korc M, Büchler MW.

Ann Surg. 1999 Jul;230(1):63-71.

32.

Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma.

Abou-Shady M, Baer HU, Friess H, Berberat P, Zimmermann A, Graber H, Gold LI, Korc M, Büchler MW.

Am J Surg. 1999 Mar;177(3):209-15.

PMID:
10219856
33.

Comparison of the fibrin-binding activities in the N- and C-termini of fibronectin.

Rostagno AA, Schwarzbauer JE, Gold LI.

Biochem J. 1999 Mar 1;338 ( Pt 2):375-86.

34.

Increased levels of transforming growth factor-beta in HIV-associated nephropathy.

Yamamoto T, Noble NA, Miller DE, Gold LI, Hishida A, Nagase M, Cohen AH, Border WA.

Kidney Int. 1999 Feb;55(2):579-92.

35.

Transforming growth factor betas and their receptors in human liver cirrhosis.

Baer HU, Friess H, Abou-Shady M, Berberat P, Zimmermann A, Gold LI, Korc M, Büchler MW.

Eur J Gastroenterol Hepatol. 1998 Dec;10(12):1031-9.

PMID:
9895050
36.

A subset of metastatic human colon cancers expresses elevated levels of transforming growth factor beta1.

Picon A, Gold LI, Wang J, Cohen A, Friedman E.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):497-504.

38.

Enhanced expression of TGF-betas and their receptors in human acute pancreatitis.

Friess H, Lu Z, Riesle E, Uhl W, Bründler AM, Horvath L, Gold LI, Korc M, Büchler MW.

Ann Surg. 1998 Jan;227(1):95-104.

39.

Expression of transforming growth factor-beta (TGF-beta) isoforms in osteosarcomas: TGF-beta3 is related to disease progression.

Kloen P, Gebhardt MC, Perez-Atayde A, Rosenberg AE, Springfield DS, Gold LI, Mankin HJ.

Cancer. 1997 Dec 15;80(12):2230-9.

PMID:
9404699
40.

Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases.

Jagirdar J, Lee TC, Reibman J, Gold LI, Aston C, Bégin R, Rom WN.

Environ Health Perspect. 1997 Sep;105 Suppl 5:1197-203.

41.

Exogenous and endogenous transforming growth factors-beta influence elastin gene expression in cultured lung fibroblasts.

McGowan SE, Jackson SK, Olson PJ, Parekh T, Gold LI.

Am J Respir Cell Mol Biol. 1997 Jul;17(1):25-35.

PMID:
9224206
42.

Differential localization of transforming growth factor-beta isoforms in human gastric mucosa and overexpression in gastric carcinoma.

Naef M, Ishiwata T, Friess H, Büchler MW, Gold LI, Korc M.

Int J Cancer. 1997 Apr 10;71(2):131-7.

43.

Studies in cranial suture biology: Part I. Increased immunoreactivity for TGF-beta isoforms (beta 1, beta 2, and beta 3) during rat cranial suture fusion.

Roth DA, Longaker MT, McCarthy JG, Rosen DM, McMullen HF, Levine JP, Sung J, Gold LI.

J Bone Miner Res. 1997 Mar;12(3):311-21.

44.

Immunolocalization of transforming growth factor beta 1, beta 2, and beta 3 and insulin-like growth factor I in premature cranial suture fusion.

Roth DA, Gold LI, Han VK, McCarthy JG, Sung JJ, Wisoff JH, Longaker MT.

Plast Reconstr Surg. 1997 Feb;99(2):300-9; discussion 310-6.

PMID:
9030135
45.

Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair.

Riesle E, Friess H, Zhao L, Wagner M, Uhl W, Baczako K, Gold LI, Korc M, Büchler MW.

Gut. 1997 Jan;40(1):73-9.

46.

Immunohistochemical localization of transforming growth factor-beta and insulin-like growth factor-I in asbestosis in the sheep model.

Lee TC, Gold LI, Reibman J, Aston C, Bégin R, Rom WN, Jagirdar J.

Int Arch Occup Environ Health. 1997;69(3):157-64.

PMID:
9049666
49.

Inward growth of colonic adenomatous polyps.

Moss SF, Liu TC, Petrotos A, Hsu TM, Gold LI, Holt PR.

Gastroenterology. 1996 Dec;111(6):1425-32.

PMID:
8942720
50.

Altered expression of transforming growth factor-beta S in chronic renal rejection.

Horvath LZ, Friess H, Schilling M, Borisch B, Deflorin J, Gold LI, Korc M, Büchler MW.

Kidney Int. 1996 Aug;50(2):489-98.

Supplemental Content

Support Center